Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest half life in humans after IV administration.
Constraint: You must select all options from a, b, c, d, or e without using any other words.
Options:
(a) CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O
(b) O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O
(c) OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
(d) COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC
(e) C[C@@H]1C(=O)O[C@H]2[C@H](O)[C@@]34[C@H]5C[C@@H](C(C)(C)C)[C@]36[C@@H](OC(=O)[C@@H]6O)O[C@@]4(C(=O)O5)[C@@]12O
Answer: e
Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest {half_life_duration__names__noun}.
Constraint: You must select all options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%half_life_duration%}
Answer: {%multiple_choice_result}
(1R,3R,6R,7S,8S,10R,11R,12R,13S,16S,17R)-8-tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione